Infant Gut Molecule: Allergy Prevention Breakthrough

What if the key to allergies was even before the first sneeze? A little-known molecule, present in the intestines of certain infants, could well transform the way we approach infant health. A new approach to preventing allergies even before they appear.

A molecule from the infant microbiota capable of slowing down allergic reactions

Imagine a molecule tiny, produced by some intestinal bacteriawhich plays a role as conductor of the immune system from birth. Indeed, from the first days of life, our body already begins to shape itself under the influence of the microbiota.

This scenario is no longer fiction. Indeed, several recent works confirm this intuition. Danish researchers have identified a substance natural to properties immuno-modulatrices very powerful in infants. For example, this compound, 4-hydroxyphényl lactate (or 4-OH-PLA), is generated by certain bifidobacteria.

Thus, it significantly reduces the production of IgE antibodies, responsible for many allergies, while leaving other immune functions intact. In other words, he slows down allergic runawaywithout weakening the natural defenses of the organism.

A strong link between the presence of bifidobacteria and a reduction in allergies in the first years of life

Today, One in three children suffers from a form allergy. Therefore, we may wonder why some are more vulnerable than others. But then, why such vulnerability from a very young age? To answer this, researchers followed 147 children for five years, studying their microbiota, the metabolites produced and their immune responses to common allergens.

They found that infants with a high concentration of bifidobactéries producing 4-OH-PLA in their stools during the first months developed significantly fewer allergic reactions subsequently. Therefore, it appears that certain bacterial profiles are naturally protective.

Thus, this observation suggests a protective role active microbiota intestinal in the early stages of immune development. And it’s not a simple correlation. In practice, 4-OH-PLA acts by modulating the immune balance from birth. In the absence of these bacteria, the immune system can overreact to harmless elements, triggering rhinitis, eczema or asthma. Balanced intestinal flora : a natural barrier against allergies.

Three natural factors that promote the presence of protective bifidobacteria in infants

But then, how can we encourage the presence of these bacteria protective ? The study points to three major factors: natural birthand exclusive breastfeeding and early contacts (with brothers, sisters, other children, etc.). These conditions facilitate natural transmission of bifidobacteria from mother to child.

In other words, the way an infant interacts with its environment can direct its entire immune trajectory. This is why these early factors deserve special attention. And in our increasingly sanitized Western societies, this beneficial colonization tends to disappear, which could partly explain the outbreak of allergic diseases.

A new preventive strategy: probiotics and enriched milks for babies at risk

Fortunately, the good news is that we can act. Concrete avenues are being studied: the development of probiotics targeted and milks enriched to stimulate the production of 4-OH-PLA. Furthermore, clinical trials are already underway in Denmark, as part of the “Begin” project, to test this approach on infants at risk.

The objective is ambitious but promising: prevent asthma and allergies upstream. In short, far from being a laboratory anecdote, this discovery changes the situation: it puts the microbiota intestinal at the heart of prevention strategies. Finally, this progress invites us, perhaps, to rethink our relationship with hygiene, childbirth and infant nutrition.